ROS (reactive oxygen species) and RNS (reactive nitrogen species) are central to the innate immunity that protects us from infection, but also contribute to degenerative diseases and possibly aging. However, ROS and RNS are increasingly recognized to contribute to physiological signalling. This review briefly describes the main interactions between ROS and RNS and shows how their origins, chemistry, metabolism and biological actions are intimately linked.
Introduction
ROS (reactive oxygen species) are a group of chemically reactive molecules derived from oxygen (O 2 ), the main members of which are superoxide (O 2 − ), H 2 O 2 and the hydroxyl radical (OH • ). ROS are an informal club and other members may include hypochlorous acid (HOCl), lipid peroxides and oxygen itself. RNS (reactive nitrogen species) are a group of chemically reactive molecules derived from nitric oxide (NO), the main members of which are peroxynitrite (ONOO − ), nitrogen dioxide (NO 2 ) and S-nitrosothiols. Other members include dinitrogen trioxide (N 2 O 3 ), various NO derivatives of fatty acids and NO itself. ROS and RNS also strongly interact with reactive sulfur species, i.e. derivatives of reduced thiols (RSH) including the thiolate anion (RS − ), thiyl radical (RS) and sulfenic acid derivative (RSOH) [1] .
Chemical interactions
NO can react directly with O 2 to produce NO 2 , which will react with a further NO to give N 2 O 3 . This reaction is slow in solution at in vivo levels of NO and O 2 ; however, it is speeded up within membranes simply because NO and O 2 Key words: cell death, mitochondrion, peroxynitrite, reactive nitrogen species, reactive oxygen species. Abbreviations used: NO, nitric oxide; NOS, nitric oxide synthase; iNOS, inducible NOS; nNOS, neuronal NOS; PKC, protein kinase C; RNS, reactive nitrogen species; ROS, reactive oxygen species; SOD, superoxide dismutase. 1 To whom correspondence should be addressed (email gcb@mole.bio.cam.ac.uk).
are more soluble (and therefore at high concentration) in membranes than in solution. NO 2 is a potent oxidizing and nitrating agent (addition of NO 2 + group e.g. to tyrosine to give 3-nitrotyrosine). N 2 O 3 is a nitrosating reagent, i.e. it adds an NO + group, either to secondary amines to give N-nitrosoamines or to thiols to give S-nitrosothiols, e.g. nitrosation of glutathione gives S-nitrosoglutathione (GSNO). Snitrosothiols can decay to NO and the thiol radical (RS • ) or transnitrosate (i.e. transfer the NO + group) to another thiol. Nitrosation of cysteine residues in proteins results in a S-nitrosated or S-nitrosylated protein (meaning the same thing, i.e. the presence of an SNO group).
Superoxide reacts with NO at the diffusion-limited rate to produce peroxynitrite. Peroxynitrite can isomerize to unreactive nitrate (NO 3 − ), or it can oxidize for example thiols to sulfenic acid derivatives or to the thiyl radical and NO 2 , or it can nitrate tyrosine. Under physiological conditions, much peroxynitrite reacts with CO 2 to give NO 2 and the carbonate radical (CO 3 •− ), which is another strong oxidant. See Scheme 1 for a summary of these interactions.
NO/RNS actions on O 2 /ROS production and consumption

NO on oxygen
NO potently increases oxygen supply to mammalian tissues by stimulating vascular relaxation. At higher concentrations, NO inhibits oxygen consumption within tissues by inhibiting mitochondrial cytochrome oxidase [2] , the main oxygen sink in tissues. Thus, because NO stimulates oxygen supply while inhibiting oxygen consumption, NO potentially increases oxygen level within mammalian tissues, which in turn may increase ROS production as the latter is often oxygen-limited.
NO on superoxide
NO increases superoxide consumption by directly reacting with it to give peroxynitrite. Peroxynitrite can irreversibly inactivate the mitochondrial form of SOD (superoxide dismutase) (Mn-SOD) [3] , but not the cytosolic form (Cu,Zn-SOD). In some cells NO can decrease superoxide levels by inhibiting cytochrome P450 enzymes that are important sources of superoxide (and H 2 O 2 ) in the vasculature and hepatic cells [4] . NO has no acute effect on superoxide production by the phagocytic NADPH oxidase [5] . But it does acutely stimulate superoxide production from mitochondria, via inhibition of the respiratory chain and reaction with ubiquinol [6] . NOSs (nitric oxide synthases) can generate superoxide and H 2 O 2 particularly under conditions where the L-arginine concentration is low or when the NOS cofactor tetrahydrobiopterin is depleted due to its oxidation by ROS or peroxynitrite [7, 8] .
Most H 2 O 2 production in cells is derived from superoxide via SODs, except that coming from various oxidases (e.g. fatty acyl-CoA oxidase) mostly located in peroxisomes. Because NO rapidly reacts with superoxide, it may potentially, acutely lower H 2 O 2 production. In our experience, this is true extracellularly, but the opposite occurs intracellularly, i.e. NO increases H 2 O 2 levels intracellularly [9] . This is probably because NO increases mitochondrial H 2 O 2 production and inhibits catalase [9] . NO acutely and reversibly inhibits catalase by binding to the haem iron, and the K i for inhibition is approx. 0.2 µM NO [10] , suggesting that the inhibition may be important in tissues expressing iNOS (inducible production from mitochondria at medium levels of NO (by mechanisms indicated above for superoxide), but inhibits production at high levels of NO, probably due to the NO scavenging of superoxide [6] . S-nitrosothiol inactivation of complex I can also reversibly increase superoxide and H 2 O 2 production [12, 13] .
NO on oxidative stress
High levels of NO invariably cause oxidative stress, which is one of the main ways that NO induces cell death [2, 12] . The oxidative stress may result from the peroxynitrite, NO 2 and N 2 O 3 derived from NO under these conditions, or alternatively from the increased H 2 O 2 levels. Peroxynitrite, NO 2 and N 2 O 3 can react directly with glutathione to deplete its level [14] . Increased H 2 O 2 levels (caused by increased mitochondrial production and inhibition of catalase) will deplete glutathione indirectly via glutathione peroxidase. See Scheme 2 for a summary of these interactions.
NO as an antioxidant
NO can act as an antioxidant by directly scavenging reactive free radicals and superoxide, inhibiting the oxidative chemistry of iron, and signalling the up-regulation of antioxidant enzymes [1, 14] .
O 2 /ROS actions on NO/RNS production and consumption
Oxygen on NO/RNS production and consumption O 2 is a substrate for all NO synthases with K m (app) of 4, 130 and 350 µM O 2 for eNOS (endothelial NOS), iNOS and nNOS (neuronal NOS) [15] , so that nNOS and iNOS may be substrate-limited by oxygen. However, O 2 also promotes some mechanisms of NO consumption: (i) at high NO levels, NO reacts directly with oxygen (particularly in membranes) and this reaction is proportional to O 2 level [16] , and (ii) mitochondrial superoxide production is proportional to oxygen level. The result of this is that oxygen may increase NO consumption, while stimulating the production of peroxynitrite, NO 2 and N 2 O 3 .
Superoxide on NO/RNS production and consumption
Superoxide has no effect on NO production, but it causes NO consumption by directly reacting with NO. Thus activation of the NADPH oxidase in neutrophils, macrophages or microglia removes all extracellular NO [5, 17] , and activation of NADPH oxidases in the vascular wall makes NO less available to cause relaxation [18] . This is likely to be an important means of regulating NO level in vivo. The product of NO and superoxide is peroxynitrite, so increased superoxide promotes the production of peroxynitrite, which may be important in inducing cell death.
H 2 O 2 on NO/RNS production and consumption H 2 O 2 has no obvious acute effect on NO production. It may stimulate iNOS induction through activation of NF-κB (nuclear factor κB), the main transcription factor mediating iNOS induction [19] . [21] .
Interactions between ROS and RNS in cell proliferation, survival and death
Low (nanomolar) concentrations of NO stimulate cell proliferation through cGMP in some mammalian cells, including endothelial cells, and thus are an important regulator of angiogenesis [22, 23] . Low concentration of NO may also block cell death in some cells and conditions via cGMP-dependent mechanisms. For example, NO is known to be involved in the late phase of ischaemic preconditioning in heart, preventing subsequent ischaemia/reperfusion-induced cell death via mechanisms that may be cGMP-dependent, may involve stimulation of ROS production leading to redox activation of PKC (protein kinase C), or may include S-nitrosation of signalling enzymes and caspases [24] [25] [26] . Medium concentrations (100 nM) of NO block cell proliferation in most cells, probably via energy depletion and oxidative stress [23] , although lower concentrations may block proliferation of vascular smooth muscle by S-nitrosation [27] . High concentrations (> 500 nM) of NO induce cell death, mainly either by oxidative/nitrosative stress-induced apoptosis or by energy depletion-induced necrosis [2, 9, 26] . H 2 O 2 has a similar doseresponse: stimulation of proliferation and possibly survival at low (submicromolar) concentrations, while blocking proliferation and inducing cell death at high (micromolar) concentrations [28] . NO-induced increases in cellular H 2 O 2 level may increase or decrease cell proliferation depending on conditions [23, 29] . NO can induce cell death via increasing H 2 O 2 levels in cells, and can synergize with H 2 O 2 to induce cell death in various ways [9] . NO/RNS/ROS may also switch apoptosis to necrosis by inhibiting caspases due to S-nitrosation or oxidation of reactive thiol residues [26, 30] . NO may synergize with superoxide to induce cell death via peroxynitrite production, so that for example iNOS and the NADPH oxidase may synergize to induce cell death by this means [31] . NO and hypoxia may also synergize to induce cell death via inhibition of mitochondrial cytochrome oxidase, in neurons and vascular wall for example [32, 33] .
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